Pam Crotty
Overview
Explore the profile of Pam Crotty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
1403
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zietara F, Crotty P, Houghton M, Tyrrell L, Coffin C, Macphail G
Can Liver J
. 2022 Aug;
3(3):276-285.
PMID: 35992530
Background: Approximately 60% of incident hepatitis C virus (HCV) infections are due to intravenous drug use; therefore, understanding the socio-demographics of people who inject drugs (PWID) is necessary to achieve...
2.
Loucks C, Lin J, Trueman J, Drogemoller B, Wright G, Chang W, et al.
Liver Int
. 2022 Feb;
42(4):796-808.
PMID: 35107877
Background & Aims: According to pivotal clinical trials, cure rates for sofosbuvir-based antiviral therapy exceed 96%. Treatment failure is usually assumed to be because of virological resistance-associated substitutions or clinical...
3.
Bomhof M, Parnell J, Ramay H, Crotty P, Rioux K, Probert C, et al.
Eur J Nutr
. 2018 May;
58(4):1735-1745.
PMID: 29779170
Purpose: In obesity and diabetes the liver is highly susceptible to abnormal uptake and storage of fat. In certain individuals hepatic steatosis predisposes to the development of non-alcoholic steatohepatitis (NASH),...
4.
Karlas T, Petroff D, Sasso M, Fan J, Mi Y, de Ledinghen V, et al.
J Hepatol
. 2017 Jan;
66(5):1022-1030.
PMID: 28039099
Background & Aims: The prevalence of fatty liver underscores the need for non-invasive characterization of steatosis, such as the ultrasound based controlled attenuation parameter (CAP). Despite good diagnostic accuracy, clinical...
5.
Borman M, Ladak F, Crotty P, Pollett A, Kirsch R, Pomier-Layrargues G, et al.
Hepatol Int
. 2015 Jul;
7(2):592-9.
PMID: 26201792
Purpose: Noninvasive tools for the detection of hepatic steatosis are needed. The Fatty Liver Index (FLI), which includes body mass index (BMI), waist circumference, triglycerides, and γ-glutamyl-transferase, has been proposed...
6.
Sadler M, Crotty P, Fatovich L, Wilson S, Rabin H, Myers R
Can J Gastroenterol Hepatol
. 2015 Apr;
29(3):139-44.
PMID: 25855877
Background: Liver disease is the third leading cause of mortality in patients with cystic fibrosis (CF). However, detection of CF-associated liver disease (CFLD) is challenging. Objective: To evaluate the diagnostic...
7.
Myers R, Crotty P, Town S, English J, Fonseca K, Tellier R, et al.
CMAJ Open
. 2015 Apr;
3(1):E62-7.
PMID: 25844371
Background: Screening for hepatitis C virus (HCV) is recommended in patients born between 1945 and 1965 ("baby boomers") in the United States. Because these patients are often screened for colorectal...
8.
Raman M, Fenton T, Crotty P, Ghosh S, Rioux K, Hundal R
Clin Chim Acta
. 2014 Aug;
438:103-6.
PMID: 25110812
Background: Malabsorptive etiologies of chronic diarrhea are important to identify. The 72-h stool for fecal fat test (FFT), the gold standard for diagnosing fat malabsorption, is fraught with limitations that...
9.
Pang J, Zimmer S, Niu S, Crotty P, Tracey J, Pradhan F, et al.
PLoS One
. 2014 Apr;
9(4):e95776.
PMID: 24755824
Background: Liver stiffness measurement (LSM) by transient elastography (TE, FibroScan) is a validated method for noninvasively staging liver fibrosis. Most hepatic complications occur in patients with advanced fibrosis. Our objective...
10.
Pang J, Pradhan F, Zimmer S, Niu S, Crotty P, Tracey J, et al.
Can J Gastroenterol Hepatol
. 2014 Mar;
28(3):143-9.
PMID: 24619636
Background: Liver stiffness measurement (LSM) using transient elastography is widely used in the management of patients with chronic liver disease. Objectives: To examine the feasibility and reliability of LSM, and...